Odyssean LLC’s Denali Therapeutics DNLI Stock Holding History
Bought
Maintained
Sold
Other funds holding DNLI
Odyssean LLC's DNLI Position: Q3 2026 in Review
Odyssean LLC increased its Denali Therapeutics (DNLI) stake by 66% in Q3 2026, buying an estimated $1.93M and bringing the position to 207,640 shares worth $4.29M. The position accounts for 0.5% of the portfolio, ranked #65.
Odyssean LLC first reported a position in DNLI in Q2 2026 and has held it in 2 quarters since. 287 funds tracked by Wall St. Rank hold DNLI as of Q3 2026.
- Odyssean LLC held 207,640 shares of Denali Therapeutics worth $4.29M as of Q3 2026.
- Odyssean LLC bought 82,578 Denali Therapeutics shares in Q3 2026, an estimated $1.93M.
- Denali Therapeutics made up 0.5% of Odyssean LLC's portfolio in Q3 2026, its #65 holding.
- Odyssean LLC first reported a position in Denali Therapeutics in Q2 2026 and has held it in 2 quarters since.
- 287 funds tracked by Wall St. Rank held Denali Therapeutics as of Q3 2026.
Based on Odyssean LLC's 13F filing for Q3 2026, filed 16 Nov 2026.